Strikingly, the combined inhibition of CDK7 and CDK9 led to an over 80% decrease in proliferation in the prostate cancer and CRPC cells but did not affect the cell lines derived from normal prostate epithelia (Fig. 4B). This evidence concerns the gene CDK9 and Familial prostate cancer.